Myasthenia Gravis Market: Industry Trends and Global Forecast, till 2035 - Distribution by Type of Disease (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis And Transient Myasthenia Gravis), Type of Drug Class (Cholinesterase Inhibitors, Chromic Immunomodulators, Monoclonal Antibodies, Rapid Immunotherapies And Other Treatments), Type of Age Group (Below 55 Years and Above 55 Years), Type of End User (Hospitals, Clinics and Other End Users), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and Leading Players